CANY
PSTX

Caxton Associates (New York)’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Caxton Associates (New York)’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,608
Closed -$75.8K – 681
2023
Q1 		$75.8K Buy
+24,608
New +$75.8K 0.01% 467